British Journal of Research Open Access

  • ISSN: 2394-3718
  • Journal h-index: 8
  • Journal CiteScore: 0.52
  • Journal Impact Factor: 0.45
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658


In Teenagers Who Smoke Cigarettes Are Nicotine Patches as Compared to Placebo Effective to Decrease the Number of Cigarettes Smoked? ��? A Systematic Review

Obumneke Amadi

Introduction:In the United States of America (USA), 70% of teenage deaths are attributed to significance health-risk behaviors, which is referred to as the contributing factors that increase the causes of morbidity and mortality among teenagers and adults, in the USA, tobacco use is identified as one of these factors by the Youth Risk Behavior Surveillance System(YRBSS). YRBSS 2013 data reported that 15.7% of high school students had smoked cigarettes and 8.8% had used smokeless tobacco. There has been success rate in over the counter real-life event in nicotine patch use but, there is need for clinical study with placebo to investigate its effectiveness.The studyinterest was in studies comparing nicotine patch therapy to other forms of treatment to better understand its strength in wide-ranging cigarette smoking approaches.The purpose of the study was to determine the effectiveness of nicotine patch in reducing the number cigarette smoked among teenage smokers, in view of the trials and several studies conducted for its relevance Objective:The aim was to examine whether nicotine patch was more effective in encouraging abstinence from cigarettes smoking compared to placebo. Methods:Systematic reviews and metaanalysesof randomized controlled trials involving the general teenage age group smokers who were current smokers-smoked less than 100 cigarettes over their lifetime and smoked at the time of the interview. Databases were searched for relevant studies reported in English that employed a randomized design published since 2000. Two authors extracted data and assessed quality. The primary outcomes and prioritization were continuous abstinence at 3, 6 and 12-month follow-up or more for the number of patients who responded to treatment.